완화 돌봄 전환 이후의 노인 말기 암환자의 약물 사용 변화 (Prescription Change in Older Adults Patients with End-Stage Cancer after Transition to Palliative Care)

서지정보

· 발행기관 : 대한임상노인학회
· 수록지 정보 : 대한임상노인학회지 / 24권 / 3호 / 115 ~ 121페이지
· 저자명 : Ji Ae Heo, Youn Seon Choi, Jae Young Park, Jung Sik Son

초록

Background: Polypharmacy is becoming increasingly common among older patients, including those with advanced cancer, presenting multiple challenges. However, recommendations for managing polypharmacy in older patients with cancer near the end of life have not yet been standardized. This study aimed to evaluate the medication prescriptions of older patients with cancer at a hospice and palliative care center in Korea to help develop new clinical practice guidelines for polypharmacy management.
Methods: We retrospectively reviewed the medical charts of 46 older patients with terminal cancer who died at the Hospice-Palliative Care Center of a teaching hospital in Korea between January 1, 2019, and December 31, 2020. We assessed the prescribed medications at four points in time from the day of transfer to the day of death. Essential medications were checked based on the International Association for Hospice and Palliative Care (IAHPC) list of essential palliative care medicines.
Results: The total numbers of drugs at the transfer day, 2 weeks before death, 1 week before death, and the day of death were 10.9 (3.82), 8.5 (3.28), 7.70 (2.75), and 5.74 (2.37), respectively. In addition, the numbers of non-IAHPC essential drugs were 8.00 (3.78), 5.48 (3.02), 4.70 (2.50), and 3.04 (1.90), respectively.
Conclusion: Our data suggest that the total number of drugs decreases and the proportion of IAHPC essential medicines increases among older patients with cancer near the end of life admitted to a hospice and palliative care center.

영어초록

Background: Polypharmacy is becoming increasingly common among older patients, including those with advanced cancer, presenting multiple challenges. However, recommendations for managing polypharmacy in older patients with cancer near the end of life have not yet been standardized. This study aimed to evaluate the medication prescriptions of older patients with cancer at a hospice and palliative care center in Korea to help develop new clinical practice guidelines for polypharmacy management.
Methods: We retrospectively reviewed the medical charts of 46 older patients with terminal cancer who died at the Hospice-Palliative Care Center of a teaching hospital in Korea between January 1, 2019, and December 31, 2020. We assessed the prescribed medications at four points in time from the day of transfer to the day of death. Essential medications were checked based on the International Association for Hospice and Palliative Care (IAHPC) list of essential palliative care medicines.
Results: The total numbers of drugs at the transfer day, 2 weeks before death, 1 week before death, and the day of death were 10.9 (3.82), 8.5 (3.28), 7.70 (2.75), and 5.74 (2.37), respectively. In addition, the numbers of non-IAHPC essential drugs were 8.00 (3.78), 5.48 (3.02), 4.70 (2.50), and 3.04 (1.90), respectively.
Conclusion: Our data suggest that the total number of drugs decreases and the proportion of IAHPC essential medicines increases among older patients with cancer near the end of life admitted to a hospice and palliative care center.

참고자료

· 없음